A previous study found that IRF1 was found to negatively regulate the function of CD4+CD25+ Treg cells by directly and specifically repressing the expression of FOXP3 gene, suggesting the negative correlation between IRF1 and FOXP3 in tumor immunity [17]. This evidence concerns the gene IRF1 and neoplasm.